Systematic mapping of the voltage-gated sodium channel outer pore using modified saxitoxins

Placeholder Show Content

Abstract/Contents

Abstract
Modulation of action potentials in electrically excitable cells is controlled by tight regulation of ion channel expression and distribution. Voltage-gated sodium channels (NaVs) represent one such class of obligatory membrane proteins, comprised of nine mammalian isoforms (NaV1.1--NaV1.9) differentially expressed in excitable tissues. Our ambition to understand the role of individual NaV subtypes in neuronal signaling motivates development of isoform-selective small molecule modulators of NaV function. The paralytic shellfish poison saxitoxin (STX) has historically been used as a critical tool for interrogating NaV structure and function and, as a result, represents an excellent template for creating such probes. However, given the marked sequence similarity between members of this protein family, designing NaV selective agents requires a comprehensive understanding of channel structure. Accordingly, we endeavored to gain insight into the three-dimensional architecture of the outer vestibule of NaV (Site 1) through a systematic structure-activity relationship (SAR) study employing saxitoxin, synthetically modified saxitoxins, and protein mutagenesis. The preparation and electrophysiological characterization of natural and non-natural STX analogues modified at six positions (N7, N9, C10, C11, C13, and N21) is described. A single synthetic route adapted from a previously disclosed strategy toward gonyautoxin-3 facilitates access to the bis-guanidinium core of STX and enables late-stage introduction of substituent groups. Mutant cycle analysis, a systematic method for mapping non-covalent ligand-receptor interactions, has been conducted with modified saxitoxins and point mutant NaVs. These studies have culminated in a revised toxin-receptor binding model, which is consistent with the large body of SAR data described in Chapters 3 and 4. During the course of this work, an acetylated variant of STX was identified with unprecedented affinity for human NaV1.7 (hNaV1.7), a channel subtype that has been implicated in pain perception. We have leveraged bis-guanidinium toxin analogues modified at positions C10/C13, C11, and C12 in supplemental studies aimed to examine a possible two-state toxin binding model. Although a two-state model cannot be completely discounted at this time, the large majority of results with STX-based probes and mutant NaVs support our revised one-state binding model. Insight gained from mutant cycle analysis has been used to rationally develop a cysteine mutant NaV that is irreversibly inhibited by nanomolar concentrations of a STX-maleimide conjugate. These findings provide a proof-of-concept for engineering NaV-mutant specific covalent inhibitors around the Site 1 locus. Future efforts to design selective, non-covalent NaV inhibitors should also be facilitated with the availability of our proposed STX-NaV binding model.

Description

Type of resource text
Form electronic; electronic resource; remote
Extent 1 online resource.
Publication date 2016
Issuance monographic
Language English

Creators/Contributors

Associated with Thomas-Tran, Rhiannon
Associated with Stanford University, Department of Chemistry.
Primary advisor Du Bois, Justin
Thesis advisor Du Bois, Justin
Thesis advisor Wandless, Thomas
Thesis advisor Wender, Paul A
Advisor Wandless, Thomas
Advisor Wender, Paul A

Subjects

Genre Theses

Bibliographic information

Statement of responsibility Rhiannon Thomas-Tran.
Note Submitted to the Department of Chemistry.
Thesis Thesis (Ph.D.)--Stanford University, 2016.
Location electronic resource

Access conditions

Copyright
© 2016 by Rhiannon Thomas-Tran
License
This work is licensed under a Creative Commons Attribution Non Commercial 3.0 Unported license (CC BY-NC).

Also listed in

Loading usage metrics...